This trial is an open label extension of a six-arm, double-blind, prospective, placebo-controlled, 7 week, dose-finding study in 33 centers in Europe. The aim of this trial is to determine safety, tolerability and efficacy of long-term application in subjects with moderate to   more »

MBP8298 is a synthetic peptide that consists of 17 amino acids linked in a sequence identical to that of a portion of human myelin basic myelin basic protein (MBP). MBP8298 has been developed for the treatment of multiple sclerosis (MS), and is based on over 26 years of research   more »